293 related articles for article (PubMed ID: 26121976)
1. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection.
Dong Z; Zhang N; Li C; Wang H; Fang Y; Wang J; Zheng X
BMC Cancer; 2015 Jun; 15():489. PubMed ID: 26121976
[TBL] [Abstract][Full Text] [Related]
2. Comparison and validation of genomic predictors for anticancer drug sensitivity.
Papillon-Cavanagh S; De Jay N; Hachem N; Olsen C; Bontempi G; Aerts HJ; Quackenbush J; Haibe-Kains B
J Am Med Inform Assoc; 2013; 20(4):597-602. PubMed ID: 23355484
[TBL] [Abstract][Full Text] [Related]
3. Computational identification of multi-omic correlates of anticancer therapeutic response.
Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
[TBL] [Abstract][Full Text] [Related]
4. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
5. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
Covell DG
PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
[TBL] [Abstract][Full Text] [Related]
6. DISIS: prediction of drug response through an iterative sure independence screening.
Fang Y; Qin Y; Zhang N; Wang J; Wang H; Zheng X
PLoS One; 2015; 10(3):e0120408. PubMed ID: 25794193
[TBL] [Abstract][Full Text] [Related]
7. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
8. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies.
Huang C; Mezencev R; McDonald JF; Vannberg F
PLoS One; 2017; 12(10):e0186906. PubMed ID: 29073279
[TBL] [Abstract][Full Text] [Related]
9. Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine.
Gupta S; Chaudhary K; Kumar R; Gautam A; Nanda JS; Dhanda SK; Brahmachari SK; Raghava GP
Sci Rep; 2016 Mar; 6():23857. PubMed ID: 27030518
[TBL] [Abstract][Full Text] [Related]
10. Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization.
Ammad-ud-din M; Georgii E; Gönen M; Laitinen T; Kallioniemi O; Wennerberg K; Poso A; Kaski S
J Chem Inf Model; 2014 Aug; 54(8):2347-59. PubMed ID: 25046554
[TBL] [Abstract][Full Text] [Related]
11. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
12. Optimal drug prediction from personal genomics profiles.
Sheng J; Li F; Wong ST
IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
[TBL] [Abstract][Full Text] [Related]
13. Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis.
Brindha GR; Rishiikeshwer BS; Santhi B; Nakendraprasath K; Manikandan R; Gandomi AH
Comput Methods Programs Biomed; 2022 Sep; 224():107027. PubMed ID: 35914385
[TBL] [Abstract][Full Text] [Related]
14. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
[TBL] [Abstract][Full Text] [Related]
15. Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors.
Zhang J; Jia J; Zhu F; Ma X; Han B; Wei X; Tan C; Jiang Y; Chen Y
Mol Biosyst; 2012 Oct; 8(10):2645-56. PubMed ID: 22833077
[TBL] [Abstract][Full Text] [Related]
16. Current Trends in Drug Sensitivity Prediction.
Cortes-Ciriano I; Mervin LH; Bender A
Curr Pharm Des; 2016; 22(46):6918-6927. PubMed ID: 27784247
[TBL] [Abstract][Full Text] [Related]
17. Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning.
Miao R; Chen HH; Dang Q; Xia LY; Yang ZY; He MF; Hao ZF; Liang Y
Pharmacol Res; 2020 Sep; 159():104932. PubMed ID: 32473309
[TBL] [Abstract][Full Text] [Related]
18. Explainable drug sensitivity prediction through cancer pathway enrichment.
Tang YC; Gottlieb A
Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
[TBL] [Abstract][Full Text] [Related]
19. Predicting cancer drug response by proteomic profiling.
Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.
Wei D; Liu C; Zheng X; Li Y
BMC Bioinformatics; 2019 Jan; 20(1):44. PubMed ID: 30670007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]